IP and its Addendum are published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Publication of IP at regular and shorter intervals is one of the main mandates of the Commission.
This Addendum has the same authority as the Indian Pharmacopoeia 2010. The General Notices, Monographs, Appendices and other contents of the Indian Pharmacopoeia that are amended by this Addendum supersede the original matter. This Addendum amends as well as adds new materials to the Indian Pharmacopoeia 2010. The General Notices and Appendices included in the Indian Pharmacopoeia 2010 apply to the contents of this Addendum as well unless specifically stated otherwise.
Addendum 2012 to IP 2010 incorporates 52 new monographs consisting of APIs, dosage forms, herbal and blood products etc. It is hoped that this addendum would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma Sector.
There are no reviews yet.